Articles Coronavirus

This is the ninth episode of our COVID-19 webcast series. In this episode Partner Mark Shaw wants to talk more about market abuse during the COVID-19 pandemic. While, on the whole, markets are very much down as a result of COVID-19, there are a number of companies in the biotech sector looking at vaccines against the SARS-CoV-2 virus and cures for COVID-19 that have the potential to make investors extremely rich. As such, there has probably never been a greater incentive to commit market abuse.

In the context of the COVID-19 outbreak, most companies are currently facing unprecedented legal issues within their organisations. As a result, they have to adapt significantly their way of working to go through this unique time in the best possible and efficient manner.

Approval of annual accounts during state of emergency18/05/2020

The aim of the law is to extend the filing and publication deadlines for annual accounts, consolidated accounts and related reports as well as the holding of annual general meetings, in order to avoid exposing company managers and directors to liability and sanctions that are disproportionate given the exceptional circumstances

Wildgen Webcast - Company Groups in Times of Financial Distress: Introduction18/05/2020

Is your group of companies faced with challenges in these difficult times? Dr. Thomas Biermeyer, specialised in corporate law and restructuring, launched a series of webcasts on the topic of company groups in times of financial distress.

Special serie COVID-19 - nÂ°8 How to deal with corporate law issues?14/05/2020

In the context of the COVID-19 outbreak, most companies are currently facing unprecedented legal issues within their organisations. As a result, they have to adapt significantly their way of working to go through this unique time in the best possible and efficient manner

DAC6 and CRS deadlines extended13/05/2020

On 8 May 2020, the European Commission released a directive proposal amending the EU Directive on Administrative Cooperation to address the urgent need for deferring certain time limits for the filing and exchange of information in the field of taxation due to the COVID-19 pandemic

DAC 6 reporting obligations starting as from 1 October 202012/05/2020

On 8 May 2020, as a result of the COVID-19 pandemic, the EU Commission proposed a three-month postponement of the starting date for the filing and exchange of information on reportable cross-border arrangements as provided under Council Directive (EU) 2018/822 of 25 May 2018 amending Directive 2011/16/EU as regards mandatory automatic exchange of information in the field of taxation (“DAC 6”).

This is the eighth episode of our COVID-19 webcast series. In this episode Partner Mark Shaw wants to look at a couple of updates from European Securities and Markets Authority (ESMA) over the last few days regarding conduct of business under MiFID and an EMIR implementation delay.

Have competition authorities adopted any official position concerning the impact of the COVID-19 crisis on the enforcement of competition law?11/05/2020

On 23 March 2020, the European Competition Network (ECN), of which the European Commission and the national competition authorities of all EU Member States are members, published a Joint Statement on the application of competition law during the COVID-19 crisis.

On 7 May 2020, the Luxembourg Parliament passed the draft law n°7540 which relates to the extension of certain deadlines relating to accounting obligations of entities of the financial sector, including, inter alia, SICARs, SIFs and UCIs, in order to take into account the exceptional circumstances caused by COVID-19 (the “Law n°7540”).